Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

NCT05768945 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05768945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05768945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
November 30, 2022
Completion date
December 31, 2023
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes